Terms: = Liver cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
28 results:
1. Nuclear Factor Related to KappaB Binding Protein (
Peng Q; Zhou M; Zuo S; Liu Y; Li X; Yang Y; He Q; Yu X; Zhou J; He Z; He Q
DNA Cell Biol; 2021 Oct; 40(10):1298-1307. PubMed ID: 34591601
[TBL] [Abstract] [Full Text] [Related]
2. KDM5A suppresses pml-RARα target gene expression and APL differentiation through repressing H3K4me2.
Xu S; Wang S; Xing S; Yu D; Rong B; Gao H; Sheng M; Tan Y; Sun X; Wang K; Xue K; Shi Z; Lan F
Blood Adv; 2021 Sep; 5(17):3241-3253. PubMed ID: 34448811
[TBL] [Abstract] [Full Text] [Related]
3. pml-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia.
Li K; Wang F; Yang ZN; Cui B; Li PP; Li ZY; Hu ZW; Zhu HH
Theranostics; 2020; 10(22):10326-10340. PubMed ID: 32929351
[TBL] [Abstract] [Full Text] [Related]
4. Successful treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
[TBL] [Abstract] [Full Text] [Related]
5. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.
Ikoma N; Chen HC; Wang X; Blum M; Estrella JS; Fournier K; Mansfield P; Ajani J; Badgwell BD
Ann Surg Oncol; 2017 Sep; 24(9):2679-2687. PubMed ID: 28332034
[TBL] [Abstract] [Full Text] [Related]
6. Arsenite inhibits the function of CD133
Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
[TBL] [Abstract] [Full Text] [Related]
7. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract] [Full Text] [Related]
8. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Zhang X; Yang XR; Sun C; Hu B; Sun YF; Huang XW; Wang Z; He YF; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J
Cancer Lett; 2015 Sep; 366(1):112-22. PubMed ID: 26118777
[TBL] [Abstract] [Full Text] [Related]
9. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.
Ferreira AK; Santana-Lemos BA; Rego EM; Filho OM; Chierice GO; Maria DA
Br J Cancer; 2013 Nov; 109(11):2819-28. PubMed ID: 24201752
[TBL] [Abstract] [Full Text] [Related]
10. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract] [Full Text] [Related]
11. A metabolic prosurvival role for pml in breast cancer.
Carracedo A; Weiss D; Leliaert AK; Bhasin M; de Boer VC; Laurent G; Adams AC; Sundvall M; Song SJ; Ito K; Finley LS; Egia A; Libermann T; Gerhart-Hines Z; Puigserver P; Haigis MC; Maratos-Flier E; Richardson AL; Schafer ZT; Pandolfi PP
J Clin Invest; 2012 Sep; 122(9):3088-100. PubMed ID: 22886304
[TBL] [Abstract] [Full Text] [Related]
12. Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma.
Zaydfudim V; Smoot RL; Clark CJ; Kendrick ML; Que FG; Farnell MB; Nagorney DM
J Gastrointest Surg; 2012 Aug; 16(8):1516-23. PubMed ID: 22644447
[TBL] [Abstract] [Full Text] [Related]
13. A pilot study of bevacizumab and interferon-α2b in ocular melanoma.
Guenterberg KD; Grignol VP; Relekar KV; Varker KA; Chen HX; Kendra KL; Olencki TE; Carson WE
Am J Clin Oncol; 2011 Feb; 34(1):87-91. PubMed ID: 20458209
[TBL] [Abstract] [Full Text] [Related]
14. Rituximab-associated infections.
Gea-Banacloche JC
Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
[TBL] [Abstract] [Full Text] [Related]
15. Massive ascites associated with all-trans retinoic acid treatment in therapy-related acute promyelocytic leukemia.
Suzukawa M; Nakazora T; Kawasaki Y; Tominaga T; Shinohara K
Intern Med; 2010; 49(5):457-60. PubMed ID: 20190483
[TBL] [Abstract] [Full Text] [Related]
16. pml-IV functions as a negative regulator of telomerase by interacting with TERT.
Oh W; Ghim J; Lee EW; Yang MR; Kim ET; Ahn JH; Song J
J Cell Sci; 2009 Aug; 122(Pt 15):2613-22. PubMed ID: 19567472
[TBL] [Abstract] [Full Text] [Related]
17. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
[TBL] [Abstract] [Full Text] [Related]
18. Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein.
Sieben M; Herzer K; Zeidler M; Heinrichs V; Leuchs B; Schuler M; Cornelis JJ; Galle PR; Rommelaere J; Moehler M
World J Gastroenterol; 2008 Jun; 14(24):3819-28. PubMed ID: 18609705
[TBL] [Abstract] [Full Text] [Related]
19. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract] [Full Text] [Related]
20. Retinoids in cancer chemoprevention.
Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
[TBL] [Abstract] [Full Text] [Related]
[Next]
